Industry: Healthcare | Publish Date: 05-Jan-2020 | No of Pages: N/A | No. of Tables: N/A | No. of Figures: N/A | Format: PDF | Report Code : N/A
The global Defibrillators Market size was valued at USD 9.47 billion in 2019, and is projected to reach USD 13.25 billion by 2030, with a CAGR of 3.1% from 2020 to 2030. Defibrillators are life-saving medical devices used to administer a therapeutic shock to a patient’s heart in life threatening situations. Defibrillator are used to treat severe complexions such as cardiac arrhythmia, ventricular fibrillation and pulseless ventricular tachycardia among others.
Heart diseases are among the top reasons of death worldwide. The increasing geriatric population and the raising cases of heart diseases among all age groups are the key driving factors of the defibrillator market. Poor lifestyle choices such as consumption of unhealthy food, lack of activity and smoking among others cause diseases such diabetes, strokes and hypertension etc. These factors are responsible for the growing cases of cardiac complications among the population. The defibrillator market growth is expected to be propelled by growing demand for sophisticated defibrillators, reforms in the healthcare sector and increasing focus of key market players to deliver cost effective and advanced defibrillators. However, the current price levels of devices along with product recalls are expected to restrict market growth.
The global defibrillator market share has been segmented on the basis of product, end user and geography. On the basis of product, the market is categorized into implantable defibrillators and external defibrillators. Implanted defibrillators are sub segmented into transvenous implantable defibrillator, Subcutaneous implantable defibrillators and CRD with pacemaker and ICD function. External defibrillators are sub segmented into manual external defibrillators, automated external defibrillators and wearable cardioverter defibrillator. On the basis of end user, the market is segmented into hospital, prehospital, public access market, alternate care market and home. Based on geography the market is segmented into North America, Europe, Asia Pacific and RoW.
North America is anticipated to hold the lion share of the market due to increasing incidences of deaths and diseases caused by cardiac complications. The Asia Pacific region is predicted to show rapid and consistent growth in terms of market share within the forecast period as the key players in this region are focusing on implementing sophisticated but cost-effective defibrillator devices to meet the demands of the immensely large population of this region.
Lucrative growth opportunities make the defibrillators market extremely competitive. Some of the major players in the market are Asahi Kasei Corporation, Stryker Corporation, Biotronic SE and Co. KG, Boston Scientific Corporation, Philips healthcare, LivaNova PLC, Medtronic PLC, Jude Medical Inc., Cardiac Science Corporation, Nihon Konden Corporation. Strategic alliances, innovative products launches are among the key strategies adopted by market players to maintain their dominance. For instance, in September 2019, Micro Port CRM Japan Co. Ltd., had announced that it had started its direct sales operation by introducing first four implants of KORA pacemakers in several regions of Japan. Also, Koninklijke Philips NV, a Netherlands based company, launched its advanced defibrillator, called HeartStart Intrepid Monitor, with IntelliSpace Connect in 2019.
The defibrillator market report provides the quantitative analysis of the current market and estimations through 2020-2030 that assists in identifying the prevailing market opportunities to capitalize on
The study comprises a deep dive analysis of the defibrillator market trend including the current and future trends for depicting the prevalent investment pockets in the market
The information related to key drivers, restraints and opportunities and their impact on the defibrillators market is provided in the report.
The market share of the players in the global defibrillator market along with their competitive analysis.
Value chain analysis in the market study provides a clear picture of the stakeholders’ roles
Implantable Defibrillator
Transvenous Implantable Cardioveter Defibrillator
Subcutaneous Implantable Cardiovereter Defibrillator
CRD with pacemaker and ICD function
External Defibrillator
Manual External Defibrillator
Automated External Defibrillator
Wearable Cardioveter Defibrillator
Hospital
Prehospital
Public Access Market
Alternate Care Market
Home
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
Rest of Asia-Pacific
RoW
Brazil
Argentina
Egypt
Israel
South Africa
Remaining Countries
REPORT SCOPE AND SEGMENTATION:
Parameters |
Details |
Analysis Period |
2019–2030 |
Base Year Considered |
2020 |
Forecast Period |
2020–2030 |
Market Size Estimation |
Billion (USD) |
Market Segmentation |
By Product (Implantable Cardioverter Defibrillator, External Defibrillator) By End User (Hospitals, Prehospital, Public Access Market, Alternate Care Market, Home) |
Geographical Segmentation |
North America (U.S., Canada, Mexico) Europe (UK, Germany, Italy, France, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, Rest of APAC), Rest of the World (Brazil, Argentina, Egypt, Israel, South Africa, Remaining Countries) |
Companies Profiled |
Asahi Kasei Corporation, Stryker Corporation, Biotronic SE and Co. KG, Boston Scientific Corporation, Philips healthcare, LivaNova PLC, Medtronic PLC, Jude Medical Inc., Cardiac Science Corporation, Nihon Konden Corporation. |
Asahi Kasei Corporation
Stryker Corporation
Biotronic SE and Co. KG
Boston Scientific Corporation
Philips healthcare,
LivaNova PLC
Medtronic PLC
Jude Medical Inc.
Cardiac Science Corporation
Nihon Konden Corporation